108 related articles for article (PubMed ID: 37750623)
1. CYP24A1, AHR, CPEB4, TRIP13, and PIK3CA genes expression in colorectal cancer patients: novel diagnostic biomarkers.
El Nakib AM; Elsaeed M; Abdelsalam RA; Wafi K; Elekhnawy E; Alrouji M; Alsaleem M; Aljarba NH; Batiha GE; Negm WA; Mostafa SA
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):7946-7955. PubMed ID: 37750623
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, IFNg, PIK3CA and CTNNB1 genes in different stage colorectal tumors.
Söylemez Z; Arıkan ES; Solak M; Arıkan Y; Tokyol Ç; Şeker H
Turk J Med Sci; 2021 Apr; 51(2):661-674. PubMed ID: 33237662
[TBL] [Abstract][Full Text] [Related]
3. Novel long noncoding RNAs upregulation may have synergistic effects on the CYP24A1 and PFDN4 biomarker role in human colorectal cancer.
Sadeghi H; Nazemalhosseini-Mojarad E; Sahebi U; Fazeli E; Azizi-Tabesh G; Yassaee VR; Savabkar S; Asadzadeh Aghdaei H; Zali MR; Mirfakhraie R
J Cell Physiol; 2021 Mar; 236(3):2051-2057. PubMed ID: 32743796
[TBL] [Abstract][Full Text] [Related]
4. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
5. CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.
Kósa JP; Horváth P; Wölfling J; Kovács D; Balla B; Mátyus P; Horváth E; Speer G; Takács I; Nagy Z; Horváth H; Lakatos P
World J Gastroenterol; 2013 May; 19(17):2621-8. PubMed ID: 23674869
[TBL] [Abstract][Full Text] [Related]
6. Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer.
Höbaus J; Hummel DM; Thiem U; Fetahu IS; Aggarwal A; Müllauer L; Heller G; Egger G; Mesteri I; Baumgartner-Parzer S; Kallay E
Int J Cancer; 2013 Sep; 133(6):1380-8. PubMed ID: 23463632
[TBL] [Abstract][Full Text] [Related]
7. A novel circular RNA hsa_circ_0060927 may serve as a potential diagnostic biomarker for human colorectal cancer.
Sadeghi H; Heiat M
Mol Biol Rep; 2020 Sep; 47(9):6649-6655. PubMed ID: 32803502
[TBL] [Abstract][Full Text] [Related]
8. [Study on the expression of TRIP13 mRNA in chronic lymphocytic leukemia B lymphocyte and the molecular mechanism of TRIP13 mediated JVM-2 cell proliferation and apoptosis].
Zhou KS; Zhang Q; Zhang WT; Liu YY; Wu SS; Zhou J; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2017 Jul; 38(7):618-622. PubMed ID: 28810332
[No Abstract] [Full Text] [Related]
9. Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
Niu L; Gao Z; Cui Y; Yang X; Li H
Med Sci Monit; 2019 Sep; 25():6660-6668. PubMed ID: 31486418
[TBL] [Abstract][Full Text] [Related]
10. TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Sheng N; Yan L; Wu K; You W; Gong J; Hu L; Tan G; Chen H; Wang Z
Cell Death Dis; 2018 Mar; 9(3):402. PubMed ID: 29540729
[TBL] [Abstract][Full Text] [Related]
11. Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR.
Zeng Q; Xie L; Zhou N; Liu M; Song X
Mol Diagn Ther; 2017 Aug; 21(4):443-451. PubMed ID: 28247181
[TBL] [Abstract][Full Text] [Related]
12. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.
Zhang X; Zhou J; Xue D; Li Z; Liu Y; Dong L
Int J Biol Macromol; 2019 May; 129():227-232. PubMed ID: 30685303
[TBL] [Abstract][Full Text] [Related]
13. MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells.
Cao Y; Huang F; Liu J; Qi H; Xiao J
Histol Histopathol; 2022 Sep; 37(9):879-888. PubMed ID: 35362548
[TBL] [Abstract][Full Text] [Related]
14. TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expression.
Yu L; Xiao Y; Zhou X; Wang J; Chen S; Peng T; Zhu X
Biomed Pharmacother; 2019 Dec; 120():109508. PubMed ID: 31648166
[TBL] [Abstract][Full Text] [Related]
15. KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients.
Mirzapoor Abbasabadi Z; Hamedi Asl D; Rahmani B; Shahbadori R; Karami S; Peymani A; Taghizadeh S; Samiee Rad F
J Clin Lab Anal; 2023 Mar; 37(5):e24868. PubMed ID: 36930789
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-203-mediated posttranscriptional deregulation of CPEB4 contributes to colorectal cancer progression.
Zhong X; Xiao Y; Chen C; Wei X; Hu C; Ling X; Liu X
Biochem Biophys Res Commun; 2015 Oct; 466(2):206-13. PubMed ID: 26361147
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Lan J; Huang J; Tao X; Gao Y; Zhang L; Huang W; Luo J; Liu C; Deng Y; Liu L; Liu X
J Cell Mol Med; 2022 May; 26(9):2673-2685. PubMed ID: 35322916
[TBL] [Abstract][Full Text] [Related]
18. CYP24A1 Inhibition Facilitates the Antiproliferative Effect of 1,25(OH)
Sun H; Jiang C; Cong L; Wu N; Wang X; Hao M; Liu T; Wang L; Liu Y; Cong X
DNA Cell Biol; 2018 Sep; 37(9):742-749. PubMed ID: 30052060
[TBL] [Abstract][Full Text] [Related]
19. TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer.
Dong L; Ding H; Li Y; Xue D; Li Z; Liu Y; Zhang T; Zhou J; Wang P
Int J Biol Macromol; 2019 Jan; 121():200-206. PubMed ID: 30267820
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP method.
Li WM; Hu TT; Zhou LL; Feng YM; Wang YY; Fang J
BMC Cancer; 2016 Jul; 16():454. PubMed ID: 27405731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
